EUVIMEDEUVIMED entdecken
Kohortenstudie

Risk Factors for Coronary Heart Disease and Stroke Among Older Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Nationwide Cohort Study

Sangwook Cheon iD, Seohui Jang iD, Eun Seok Kang iD, Jihun Song, Jaewon Khil, Seokjin Kong iD, Yihyun Kim, Jin Hyun Park iD, Minjeong Kang iD, Jeongin Lee iD, Taeho Kwak iD, Hye Jun Kim iD und 3 weitere

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.046339 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Sangwook Cheon und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Korea University College of Medicine Seoul Republic of Korea. Hauptthemen laut MEDLINE: Coronary Disease, Stroke, Fatty Liver. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Older adults with metabolic dysfunction–associated steatotic liver disease have elevated cardiovascular disease (CVD) risk, yet conventional models, such as the Framingham Risk Score, rely on linear assumptions and were developed for younger populations. Nonlinear machine learning approaches may improve risk prediction in this high‐risk group.

Methods

Using Korean National Health Insurance Service data, this population‐based cohort study followed up 67 575 adults, aged ≥65 years, with metabolic dysfunction–associated steatotic liver disease (assessed 2009–2010) for incident CVD, coronary heart disease, and stroke from 2011 to 2019. Cox proportional hazards (CoxPH) models identified time‐to‐event predictors, whereas an extreme gradient boosting (XGBoost)–based survival model explored nonlinear associations and predicted 9‐year CVD risk.

Results

Both CoxPH and XGBoost models outperformed the Framingham Risk Score, with CoxPH showing slightly better discrimination than XGBoost in the validation sets. The 2 models identified broadly similar leading predictors. For coronary heart disease, both identified Charlson comorbidity index, antiplatelet agent use, and serum creatinine among the most important predictors. In the CoxPH model, the Charlson comorbidity index had the highest explained relative risk (0.031), and the XGBoost model also ranked Charlson comorbidity index first by Shapley Additive Explanations value (0.159). For stroke, both models identified age, Charlson comorbidity index, and antiplatelet agent use as the top 3 predictors, with age ranked first (explained relative risk, 0.065; Shapley Additive Explanations, 0.239). Similar findings were observed for total CVD.

Conclusions

In older adults with metabolic dysfunction–associated steatotic liver disease, CoxPH and survival XGBoost showed similar predictive performance and identified key predictors not emphasized in traditional models, like the Framingham Risk Score. These findings underscore limitations of applying younger‐population–based tools to older adults with metabolic dysfunction–associated steatotic liver disease and support the development of tailored CVD risk models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary DiseaseStrokeFatty LiverHumansMaleAgedRepublic of KoreaFemaleRisk AssessmentRisk FactorsIncidenceAged, 80 and overComorbidityAge Factors

Stichwörter der Autor:innen

coronary heart diseasemetabolic dysfunction–associated steatotic liver diseaseolder adultsstroke

Autor:innen und Institutionen

  • Department of Medicine Korea University College of Medicine Seoul Republic of Korea.
  • Department of Biomedical Informatics Korea University College of Medicine Seoul Republic of Korea.
  • Biomedical Research Center Korea University Guro Hospital Seoul Republic of Korea.

ORCID-Profile: Sangwook Cheon, Seohui Jang, Eun Seok Kang, Seokjin Kong, Jin Hyun Park, Minjeong Kang, Jeongin Lee, Taeho Kwak, Hye Jun Kim, Jinhyeok Choi, Hwamin Lee, Seogsong Jeong

Zitieren

APA

Cheon, S., Jang, S., Kang, E. S., Song, J., Khil, J., Kong, S., Kim, Y., Park, J. H., Kang, M., Lee, J., Kwak, T., Kim, H. J., Choi, J., Lee, H., & Jeong, S. (2026). Risk Factors for Coronary Heart Disease and Stroke Among Older Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Nationwide Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.046339

Vancouver

Cheon S, Jang S, Kang ES, Song J, Khil J, Kong S, et al. Risk Factors for Coronary Heart Disease and Stroke Among Older Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Nationwide Cohort Study. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.046339

BibTeX
@article{Cheon2026,
  author = {Cheon, Sangwook and Jang, Seohui and Kang, Eun Seok and Song, Jihun and Khil, Jaewon and Kong, Seokjin and Kim, Yihyun and Park, Jin Hyun and Kang, Minjeong and Lee, Jeongin and Kwak, Taeho and Kim, Hye Jun and Choi, Jinhyeok and Lee, Hwamin and Jeong, Seogsong},
  title = {Risk Factors for Coronary Heart Disease and Stroke Among Older Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Nationwide Cohort Study},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.046339}
}
Kostenlos starten →